Literature DB >> 1955385

Duocarmycins, new antitumor antibiotics produced by Streptomyces; producing organisms and improved production.

M Ichimura1, T Ogawa, S Katsumata, K Takahashi, I Takahashi, H Nakano.   

Abstract

Six duocarmycins have been discovered during our search for new antitumor antibiotics and they showed extremely potent cytotoxic activity with IC50 values of 10(-12) M-10(-9) M on HeLa S3 cell. Three different producing strains isolated from soils were taxonomically assigned as Streptomyces. Duocarmycin A was unstable in culture broth, so improved culture conditions were designed to produce a high titer of duocarmycins B1, B2, C1 and C2 which are halogenated seco-compounds of duocarmycin A. Duocarmycin SA, one of the most potent cytotoxic agents yet discovered, was shown to be more stable in culture media than duocarmycin A, despite the structural similarity on their spirocyclopropylhexadienone moiety. In contrast to the duocarmycin A fermentation, no halogenated seco-compounds of duocarmycin SA were detected in culture broth supplemented with Br- or Cl-. All duocarmycins could be produced using one producing strain with improved media and culture conditions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1955385     DOI: 10.7164/antibiotics.44.1045

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  7 in total

1.  Palladium (II/IV) catalyzed cyclopropanation reactions: scope and mechanism.

Authors:  Thomas W Lyons; Melanie S Sanford
Journal:  Tetrahedron       Date:  2009-04-18       Impact factor: 2.457

2.  The reversible DNA-alkylating activity of duocarmycin and its analogues.

Authors:  A Asai; S Nagamura; H Saito; I Takahashi; H Nakano
Journal:  Nucleic Acids Res       Date:  1994-01-11       Impact factor: 16.971

Review 3.  CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents.

Authors:  D L Boger; D S Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

4.  Use of KW-2189, a DNA minor groove-binding agent, in patients with hepatocellular carcinoma: a north central cancer treatment group (NCCTG) phase II clinical trial.

Authors:  Steven R Alberts; Vera J Suman; Henry C Pitot; John K Camoriano; Joseph Rubin
Journal:  J Gastrointest Cancer       Date:  2007

5.  Characterization of colibactin-associated mutational signature in an Asian oral squamous cell carcinoma and in other mucosal tumor types.

Authors:  Arnoud Boot; Alvin W T Ng; Fui Teen Chong; Szu-Chi Ho; Willie Yu; Daniel S W Tan; N Gopalakrishna Iyer; Steven G Rozen
Journal:  Genome Res       Date:  2020-07-06       Impact factor: 9.043

6.  Synthesis and biological evaluation of a novel pentagastrin-toxin conjugate designed for a targeted prodrug mono-therapy of cancer.

Authors:  Lutz F Tietze; Olaf Panknin; Birgit Krewer; Felix Major; Ingrid Schuberth
Journal:  Int J Mol Sci       Date:  2008-05-20       Impact factor: 6.208

7.  Cyclization of free radicals at the C-7 position of ethyl indole-2-carboxylate derivatives: an entry to a new class of Duocarmycin Analogues.

Authors:  Naim H Al-Said; Khaled Q Shawakfeh; Wasim N Abdullah
Journal:  Molecules       Date:  2005-12-31       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.